Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review-Reference-Cited by-同舟云学术

Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review

Published:2020-11 Issue:11 Volume:23 Page:1497-1508
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Luyendijk Marianne,Vernooij Robin W.M.,Blommestein Hedwig M.,Siesling Sabine,Uyl-de Groot Carin A.

Funder

Netherlands Comprehensive Cancer Organisation

Erasmus School of Health Policy & Management

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference59 articles.

1. Using real-world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies;Makady;PharmacoEconomics,2018

2. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence;Booth;Br J Cancer,2014

3. Design and analysis issues for economic analysis alongside clinical trials;Marshall;Med Care,2009

4. Real-world evidence - what is it and what can it tell us?;Sherman;N Engl J Med,2016

5. Do contemporary randomized controlled trials meet ESMO thresholds for meaningful clinical benefit?;Del Paggio;Ann Oncol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020;Cancers;2024-04-13

2. DAta Linkage to Enhance Cancer Care (DaLECC): Protocol of a Large Australian Data Linkage Study;International Journal of Environmental Research and Public Health;2023-05-29